Arcangelo Liso
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
IGFBP-6 as a potential therapeutic target in musculoskeletal disorders.
Journal: Expert opinion on therapeutic targets
Published: March 03, 2026
Ensemble threshold Boolean modeling reveals robust attractors and regulatory drivers in pediatric leukemia.
Journal: Computers in biology and medicine
Published: February 04, 2026
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
Journal: Hematological oncology
Published: October 18, 2025
Correction: Longhitano et al. The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress. Antioxidants 2022, 11, 275.
Journal: Antioxidants (Basel, Switzerland)
Published: June 03, 2025
Redox Biology and Insulin-like Growth Factor-Binding Protein-6: A Potential Relationship.
Journal: Biology
Published: April 30, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).
Journal: British journal of haematology
Published: March 25, 2025
Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases.
Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases.
Journal: International journal of molecular sciences
Published: June 21, 2024
Last Updated: 09/26/2026